How to tackle rising rates of liver disease in the UK: All health professionals must strive to detect risk factors for liver disease and intervene early to manage them

BMJ (Online)

Volumn 346, Issue 7895, 2013, Pages

  Bhala, Neeraj ^a   Aithal, Guruprasad ^b   Ferguson, James ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b NIHR NOTTINGHAM BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; HEPATITIS B VACCINE;

ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER IDENTIFICATION TEST; ALCOHOLISM; BEHAVIOR CHANGE; CAUSE OF DEATH; DRINKING BEHAVIOR; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH PERSONNEL ATTITUDE; HEALTH PROMOTION; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION TEST; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONALCOHOLIC FATTY LIVER; OBESITY; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT REFERRAL; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; RISK ASSESSMENT; RISK REDUCTION; SCREENING TEST; UNITED KINGDOM;

ALCOHOLISM; FEMALE; GREAT BRITAIN; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER DISEASES; MALE; OBESITY; RISK FACTORS;

EID: 84874049440     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f807     Document Type: Editorial

References (14)

1. Department of Health. Chief medical officer publishes her first annual report. 2012. www.dh.gov.uk/health/2012/11/cmo/.
2. WHO. European health for all database. www.euro.who.int/en/what-we-do/ data-and-evidence/databases/european-health-for-all-database-hfa-db2.
3. UK National Statistics. Causes of death. www.statistics.gov.uk/hub/ health-social-care/health-of-the-population/causes-of-death.
4. Kaner E, Bland M, Cassidy P, Coulton S, Dale V, Deluca P, et al. Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomised controlled trial. BMJ 2013; 346:e8501.
5. Pilling S, Yesufu-Udechuku A, Taylor C, Drummond C; Guideline Development Group. Diagnosis, assessment, and management of harmful drinking and alcohol dependence: summary of NICE guidance. BMJ 2011; 342:d700.
6. Jonas DE, Garbutt JC, Amick HR, Brown JM, Brownley KA, Council CL, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the US Preventive Services Task Force. Ann Intern Med 2012; published online 25 Sep.
7. Liu B, Balkwill A, Reeves G, Beral V; Million Women Study Collaborators. Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ 2010; 340:c912.
8. Armstrong MJ, Houlihan DD, Bentham L, Shaw JC, Cramb R, Olliff S, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol 2012; 56:234-40.
9. NHS. Liver disease patient landscape and care provision. 2011. www.liver.nhs.uk/document.php?o=26.
10. Thomas D, Zoulim F. New challenges in viral hepatitis. Gut 2012; 61(suppl 1):i1-5.
11. Cobbold JF, Anstee QM, Thomas HC. Investigating mildly abnormal serum aminotransferase values. BMJ 2010; 341:c4039.
12. McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010; 59:1265-9.
13. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 2006; 367:52-6.
14. Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009; 373:2234-46.